Murat Ayhan

8PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 11, 2026
Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinoma.

Murat Ayhan, Akif Dogan, Sevinç Hallaç Keser

|Dec 30, 2025
Real-World Experience with Non-Metastatic Male Breast Cancer: A 222-Patient Multicenter Study from the Turkish Oncology Group (TOG).

Ülkü Yalçıntaş Arslan, Ferit Aslan, Murat Ayhan

|Feb 17, 2022
The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study.

Muhammed Mustafa Atci, Baran Akagunduz, Metin Demir

|Nov 30, 2021
Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis?

Kadriye Terzioğlu, Murat Ayhan

|Sep 24, 2021
Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient?

Esra Özyurt, Serhat Özçelik, Heves Sürmeli

|Aug 09, 2021
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study.

Ibrahim Cil, Ahmet Kucukarda, Muhammed Mustafa Atcı

Pageof 2

Frequent Collaborators

2 joint publications

Muhammed Mustafa Atci

2 joint publications

Melike Ozcelik

2 joint publications

Seval Ay

2 joint publications

Baran Akagunduz